Results
71,130 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | BIOS Fund I, LPDirector, 10% Owner |  ACTUACTUATE THERAPEUTICS, INC.Grant or award | A | — 682.9K sh | Oct 30, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 30, 2026 |
| 9 | Markley John D. Jr.Director |  IDCCInterDigital, Inc.Grant or award | A | — 8 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 195.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | vant Hoff GrahamDirector |  ANNAAleAnna, Inc.Option exercise | M | — 20.2K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Gillman Joan HDirector | IDCCInterDigital, Inc. Grant or award | A | — 49 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Sotomayor RafaelCEO & President |  NXPINXP Semiconductors N.V.Grant or award | A | — 20.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 126.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Jacobs Kevin JSee Remarks |  HLTHilton Worldwide Holdings Inc.Option exercise | M | — 28.5K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Aberle Derek KDirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 368.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | West Michael LCEO - Moody's Ratings |  MCOMOODYS CORP /DE/Option exercise | M | — 6,820 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Martino Roxanne MDirector |  VTRVentas, Inc.Grant or award | A | $1,500 18 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 9 | Kritzmacher John ADirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 87.7K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Carey Stephen P.SVP & CFO |  ANIPANI PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $208K 2,850 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Armaly SamirDirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Mattis Julia CChief Licensing Officer | IDCCInterDigital, Inc. Grant or award | A | — 19 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Brezski RichardChief Financial Officer | IDCCInterDigital, Inc. Grant or award | A | — 31 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 126.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Jacobs Kevin JSee Remarks | HLTHilton Worldwide Holdings Inc. Option exercise | M | — 12.8K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.5K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Hoffmann Michael ThomasEVP & General Counsel | NXPINXP Semiconductors N.V. Grant or award | A | — 1,788 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 87.7K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Baker JeffPrincipal Accounting Officer |  CRWVCoreWeave, Inc.Option exercise | M | — 12.5K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | Wunsch Scott MCEO, Logistics |  SRTAStrata Critical Medical, Inc.Grant or award | A | — 1,416 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 269.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 65.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 36.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 368.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 195.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Rankin Jean FDirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Smith Maurice SDirector | VTRVentas, Inc. Grant or award | A | $1,500 18 sh | Oct 30, 2026 traded Oct 30, 2026 |